Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse? (Q78128660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

A C Braud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

B Asselain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

S Scholl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

A De La Rochefordière

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

T Palangie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

V Dieras

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J Y Pierga

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

T Dorval

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

M Jouve

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

P Beuzeboc

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

P Pouillart

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

392-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

Age as a prognostic factor in breast cancer

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Age as prognostic factor in premenopausal breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Younger women with breast carcinoma have a poorer prognosis than older women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Neoadjuvant chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Is primary chemotherapy useful for all patients with primary invasive breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900393-1

7 January 2021

10.1016/S0959-8049(98)00393-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448288%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference